{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T10:47:02Z","timestamp":1780656422223,"version":"3.54.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/j.ejmech.2021.113950","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T00:23:33Z","timestamp":1635380613000},"page":"113950","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"special_numbering":"C","title":["Construction and activity evaluation of novel benzodioxane derivatives as dual-target antifungal inhibitors"],"prefix":"10.1016","volume":"227","author":[{"given":"Yunfei","family":"An","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenxia","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Honglei","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiyan","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9224-0033","authenticated-orcid":false,"given":"Jun","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2021.113950_bib1","doi-asserted-by":"crossref","first-page":"e383","DOI":"10.1016\/S1473-3099(17)30316-X","article-title":"The global problem of antifungal resistance: prevalence, mechanisms, and management","volume":"17","author":"Perlin","year":"2017","journal-title":"Lancet Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113950_bib2","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1111\/myc.12928","article-title":"Dermatological manifestations of fungal infection in patients with febrile neutropaenia: a review of the literature","volume":"62","author":"Maddy","year":"2019","journal-title":"Mycoses"},{"key":"10.1016\/j.ejmech.2021.113950_bib3","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1177\/1535370220939862","article-title":"Fungal infection risks associated with the use of cytokine antagonists and immune checkpoint inhibitors","volume":"245","author":"Li","year":"2020","journal-title":"Exp. Biol. Med."},{"key":"10.1016\/j.ejmech.2021.113950_bib4","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1093\/jac\/dku355","article-title":"Antifungal drugs during pregnancy: an updated review","volume":"70","author":"Pilmis","year":"2020","journal-title":"J.\u00a0Antimicrob. Chemother."},{"key":"10.1016\/j.ejmech.2021.113950_bib5","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mib.2018.02.005","article-title":"Antifungal drug resistance: evolution, mechanisms and impact","volume":"45","author":"Revie","year":"2018","journal-title":"Curr. Opin. Microbiol."},{"key":"10.1016\/j.ejmech.2021.113950_bib6","doi-asserted-by":"crossref","first-page":"112645","DOI":"10.1016\/j.ejmech.2020.112645","article-title":"Design, synthesis and bioactivity evaluation of novel arylalkene-amide derivatives as dual-target antifungal inhibitors","volume":"205","author":"Sun","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113950_bib7","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.prosdent.2019.12.025","article-title":"Efficacy of antifungal drugs in the treatment of oral candidiasis: a Bayesian network meta-analysis","volume":"125","author":"Fang","year":"2021","journal-title":"J.\u00a0Prosthet. Dent"},{"key":"10.1016\/j.ejmech.2021.113950_bib8","doi-asserted-by":"crossref","first-page":"312","DOI":"10.3390\/antibiotics9060312","article-title":"Candidiasis and mechanisms of antifungal resistance","volume":"9","author":"Bhattacharya","year":"2020","journal-title":"Antibiotics"},{"key":"10.1016\/j.ejmech.2021.113950_bib9","doi-asserted-by":"crossref","first-page":"2554","DOI":"10.2174\/1568026619666191025153124","article-title":"The chemistry of drugs to treat Candida albicans","volume":"19","author":"Ortiz","year":"2019","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113950_bib10","first-page":"112025","article-title":"Dual-target inhibitors based on HDACs: novel antitumor agents for cancer therapy","volume":"188","author":"Liu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113950_bib11","doi-asserted-by":"crossref","first-page":"25","DOI":"10.7150\/jca.32765","article-title":"Recombinant dual-target MDM2\/MDMX inhibitor reverses doxorubicin resistance through activation of the TAB1\/TAK1\/p38 MAPK pathway in wild-type p53 multidrug-resistant breast cancer cells","volume":"11","author":"Fan","year":"2020","journal-title":"J.\u00a0Cancer"},{"key":"10.1016\/j.ejmech.2021.113950_bib12","doi-asserted-by":"crossref","first-page":"651","DOI":"10.2174\/1389200215666141125121511","article-title":"Drug interactions between nine antifungal agents and drugs metabolized by human cytochromes P450","volume":"15","author":"Niwa","year":"2014","journal-title":"Curr. Drug Metabol."},{"key":"10.1016\/j.ejmech.2021.113950_bib13","doi-asserted-by":"crossref","first-page":"e1719","DOI":"10.1128\/AAC.01719-20","article-title":"The future of antifungal drug therapy: novel compounds and targets","volume":"65","author":"Mota Fernandes","year":"2021","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113950_bib14","doi-asserted-by":"crossref","first-page":"8271471","DOI":"10.1155\/2020\/8271471","article-title":"Eradication of lomentospora prolificans osteomyelitis of the wrist with combination antifungal therapy, voriconazole bone cement, and surgical debridement","volume":"2020","author":"Lee","year":"2020","journal-title":"Case Reports in Orthopedics"},{"key":"10.1016\/j.ejmech.2021.113950_bib15","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.3109\/13880209.2014.900808","article-title":"Possible mechanisms of the antifungal activity of fluconazole in combination with terbinafine against Candida albicans","volume":"52","author":"Khodavandi","year":"2014","journal-title":"Pharm. Biol."},{"key":"10.1016\/j.ejmech.2021.113950_bib16","doi-asserted-by":"crossref","first-page":"4309","DOI":"10.3390\/molecules24234309","article-title":"Concepts and core principles of fragment-based drug design","volume":"24","author":"Kirsch","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.ejmech.2021.113950_bib17","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.2174\/1568026619666181130134250","article-title":"Counting on fragment based drug design approach for drug discovery","volume":"18","author":"Kashyap","year":"2018","journal-title":"Curr. Top. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113950_bib18","doi-asserted-by":"crossref","first-page":"6728","DOI":"10.1074\/jbc.M117.778308","article-title":"Structural analyses of Candida albicans sterol 14 alpha-demethylase complexed with azole drugs address the molecular basis of azole-mediated inhibition of fungal sterol biosynthesis","volume":"292","author":"Hargrove","year":"2017","journal-title":"J.\u00a0Biol. Chem."},{"key":"10.1016\/j.ejmech.2021.113950_bib19","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1021\/acsmedchemlett.0c00017","article-title":"Construction and evaluation of molecular models: guide and design of novel SE inhibitors","volume":"11","author":"An","year":"2020","journal-title":"ACS Med. Chem. Lett."},{"key":"10.1016\/j.ejmech.2021.113950_bib20","doi-asserted-by":"crossref","first-page":"26302","DOI":"10.1039\/C9RA03713F","article-title":"Construction of antifungal dual-target (SE, CYP51) pharmacophore models and the discovery of novel antifungal inhibitors","volume":"9","author":"Dong","year":"2019","journal-title":"RSC Adv."},{"key":"10.1016\/j.ejmech.2021.113950_bib21","doi-asserted-by":"crossref","DOI":"10.1128\/AAC.02586-18","article-title":"The evolution of azole resistance in Candida albicans sterol 14\u03b1-demethylase (CYP51) through incremental amino acid substitutions","volume":"63","author":"Warrilow","year":"2019","journal-title":"Antimicrob. Agents Chemother."},{"key":"10.1016\/j.ejmech.2021.113950_bib22","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1021\/acs.jmedchem.7b00404","article-title":"Fragment-based drug discovery of phosphodiesterase inhibitors","volume":"61","author":"Svensson","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113950_bib23","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.ejmech.2019.05.047","article-title":"Design, synthesis, and structure-activity relationship studies of l-amino alcohol derivatives as broad-spectrum antifungal agents","volume":"177","author":"Zhao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113950_bib24","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1016\/j.bmc.2019.02.009","article-title":"Design, synthesis and biological evaluation of amide-pyridine derivatives as novel dual-target (SE, CYP51) antifungal inhibitors","volume":"27","author":"Sun","year":"2019","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113950_bib25","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/j.bmc.2016.11.051","article-title":"Discovery of biphenyl imidazole derivatives as potent antifungal agents: design, synthesis, and structure-activity relationship studies","volume":"25","author":"Zhao","year":"2017","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113950_bib26","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1016\/j.bmcl.2019.07.037","article-title":"Design, synthesis and evaluation of biphenyl imidazole analogues as potent antifungal agents","volume":"29","author":"Zhao","year":"2019","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2021.113950_bib27","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1039\/C8MD00230D","article-title":"Structure-based virtual screening and ADME\/T-based prediction analysis for the discovery of novel antifungal CYP51 inhibitors","volume":"9","author":"Sun","year":"2018","journal-title":"Medchemcomm"},{"key":"10.1016\/j.ejmech.2021.113950_bib28","doi-asserted-by":"crossref","first-page":"112360","DOI":"10.1016\/j.ejmech.2020.112360","article-title":"Design, synthesis, and biological evaluation of novel miconazole analogues containing selenium as potent antifungal agents","volume":"198","author":"Xu","year":"2020","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113950_bib29","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1021\/acsinfecdis.9b00197","article-title":"Drug repurposing of haloperidol: discovery of new benzocyclane derivatives as potent antifungal agents against cryptococcosis and candidiasi","volume":"6","author":"Ji","year":"2020","journal-title":"ACS Infect. Dis."},{"key":"10.1016\/j.ejmech.2021.113950_bib30","doi-asserted-by":"crossref","first-page":"111689","DOI":"10.1016\/j.ejmech.2019.111689","article-title":"Combating fluconazole-resistant fungi with novel \u03b2-azole-phenylacetone derivatives","volume":"183","author":"Zhao","year":"2019","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113950_bib31","doi-asserted-by":"crossref","first-page":"112991","DOI":"10.1016\/j.ejmech.2020.112991","article-title":"Novel naphthylamide derivatives as dual-target antifungal inhibitors: design, synthesis and biological evaluation","volume":"210","author":"An","year":"2021","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113950_bib32","doi-asserted-by":"crossref","first-page":"103749","DOI":"10.1016\/j.bioorg.2020.103749","article-title":"Potent arylamide derivatives as dual-target antifungal agents: design, synthesis, biological evaluation, and molecular docking studies","volume":"99","author":"Dong","year":"2020","journal-title":"Bioorg. Chem."},{"key":"10.1016\/j.ejmech.2021.113950_bib33","doi-asserted-by":"crossref","first-page":"3531","DOI":"10.1016\/j.ejmech.2010.03.007","article-title":"Design, synthesis and antifungal activity of isosteric analogues of benzoheterocyclic N-myristoyl transferase inhibitors","volume":"45","author":"Sheng","year":"2010","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2021.113950_bib34","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jmgm.2017.07.031","article-title":"Comparison and analysis of the structures and binding modes of antifungal SE and CYP51 inhibitors","volume":"77","author":"Sun","year":"2017","journal-title":"J.\u00a0Mol. Graph. Model."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421007996?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523421007996?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T14:38:53Z","timestamp":1759329533000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523421007996"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1]]},"references-count":34,"alternative-id":["S0223523421007996"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113950","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Construction and activity evaluation of novel benzodioxane derivatives as dual-target antifungal inhibitors","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2021.113950","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}],"article-number":"113950"}}